The Journal of Urology · 2005 · 201 citations · 14 references
MedicinePharmacologyUrologyAntimicrobial PharmacotherapyBladder ManagementUrologic SurgeryInterstitial CystitisUrinary Tract InfectionsUrologic InterventionsIntravesical OnabotulinumtoxinaUrinary Bladder Inflammation
PURPOSE: Interstitial cystitis is a painful bladder condition of unknown etiology and poorly understood pathophysiology. Current therapies have met with limited success. Vanilloid receptor agonists such as resiniferatoxin (RTX) desensitize C-fibers that transmit pain; it is hypothesized that such drugs will be effective in the treatment of interstitial cystitis and painful bladder syndrome by decreasing the pain that leads to urinary frequency and urgency. MATERIALS AND METHODS: A randomized, double-blind, placebo controlled study was conducted in 163 patients with interstitial cystitis. Participants were randomly assigned to receive a single intravesical dose of 50 ml of either RTX 0.01 microM, 0.05 microM, 0.10 microM, or placebo. Safety and efficacy was evaluated over 12 weeks. The primary efficacy endpoint was the Global Response Assessment, a 7-point scale rating overall change in symptoms of interstitial cystitis after 4 weeks. Secondary efficacy endpoints included reduction in pain, urgency, frequency, nocturia, average void volume, and the O'Leary-Sant Symptom and Problem Indexes. RESULTS: RTX did not improve overall symptoms, pain, urgency, frequency, nocturia, or average void volume during 12 weeks followup. RTX resulted in a dose-dependent increase in the incidence of instillation pain, but was otherwise generally well tolerated. CONCLUSIONS: In the largest prospective, randomized clinical trial reported to date with intravesical vanilloid therapy, single administration of RTX at doses of 0.01 microM to 0.10 microM was not effective in patients with interstitial cystitis.
14
Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin Receptor
Michael J. Caterina, Andreas Leffler, Annika B. Malmberg et al. · Science · 2000 · 3.5K citations
Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation
Maria Nolano, Donald A. Simone, Gwen Wendelschafer‐Crabb et al. · Pain · 1999 · 468 citations
Medicine, Dermatology, Pharmacology +17
Vanilloid receptor 1 immunoreactivity in inflamed human bowel
Y. Yiangou, P. Facer, N. Dyer et al. · The Lancet · 2001 · 357 citations
EPIDEMIOLOGY OF INTERSTITIAL CYSTITIS: A POPULATION BASED STUDY
Gary C. Curhan, Frank E. Speizer, David J. Hunter et al. · The Journal of Urology · 1999 · 290 citations